EP1005355A4 - Procede et compositions de traitement des ulceres gastro-intestinaux - Google Patents

Procede et compositions de traitement des ulceres gastro-intestinaux

Info

Publication number
EP1005355A4
EP1005355A4 EP98919780A EP98919780A EP1005355A4 EP 1005355 A4 EP1005355 A4 EP 1005355A4 EP 98919780 A EP98919780 A EP 98919780A EP 98919780 A EP98919780 A EP 98919780A EP 1005355 A4 EP1005355 A4 EP 1005355A4
Authority
EP
European Patent Office
Prior art keywords
treating gastrointestinal
gastrointestinal ulcers
compositions therefor
therefor
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98919780A
Other languages
German (de)
English (en)
Other versions
EP1005355A1 (fr
Inventor
Sandor Szabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHEMO PATHOLOGY RESOUR CENTER Inc
RADIX ORGANIZATION Inc
CHEMO PATHOLOGY RESOUR CT Inc
Original Assignee
CHEMO PATHOLOGY RESOUR CENTER Inc
CHEMO PATHOLOGY RESOUR CT Inc
RADIX ORGANIZATION Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHEMO PATHOLOGY RESOUR CENTER Inc, CHEMO PATHOLOGY RESOUR CT Inc, RADIX ORGANIZATION Inc filed Critical CHEMO PATHOLOGY RESOUR CENTER Inc
Publication of EP1005355A1 publication Critical patent/EP1005355A1/fr
Publication of EP1005355A4 publication Critical patent/EP1005355A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98919780A 1997-04-15 1998-04-15 Procede et compositions de traitement des ulceres gastro-intestinaux Withdrawn EP1005355A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4302397P 1997-04-15 1997-04-15
US43023P 1997-04-15
PCT/US1998/007686 WO1998046249A1 (fr) 1997-04-15 1998-04-15 Procede et compositions de traitement des ulceres gastro-intestinaux

Publications (2)

Publication Number Publication Date
EP1005355A1 EP1005355A1 (fr) 2000-06-07
EP1005355A4 true EP1005355A4 (fr) 2002-07-17

Family

ID=21925042

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98919780A Withdrawn EP1005355A4 (fr) 1997-04-15 1998-04-15 Procede et compositions de traitement des ulceres gastro-intestinaux

Country Status (2)

Country Link
EP (1) EP1005355A4 (fr)
WO (1) WO1998046249A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121143A2 (fr) * 1998-03-27 2001-08-08 Dorothea J. Eicher Facteur de croissance endotheliale vasculaire (vegf) et facteur de croissance endotheliale vasculaire c (vegf-c) utilises comme supplements
AU2006259408A1 (en) * 2005-06-17 2006-12-28 Genentech, Inc. Use of VEGF for wound healing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269408A2 (fr) * 1986-11-26 1988-06-01 Genentech, Inc. TGF-Bêta pour le traitement de maladies inflammatoires
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
WO1996006641A1 (fr) * 1994-08-29 1996-03-07 Prizm Pharmaceuticals, Inc. Conjugues du facteur de croissance endothelial vasculaire avec des agents cibles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269408A2 (fr) * 1986-11-26 1988-06-01 Genentech, Inc. TGF-Bêta pour le traitement de maladies inflammatoires
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
WO1996006641A1 (fr) * 1994-08-29 1996-03-07 Prizm Pharmaceuticals, Inc. Conjugues du facteur de croissance endothelial vasculaire avec des agents cibles

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRYAN WILLIAMS: "Vascular permeability/vascular endothelial growth factors: a potential role in the pathogenesis and treatment of vascular diseases", VASCULAR MEDICINE, vol. 1, no. 4, 1996, pages 251 - 258, XP001070847 *
FAVARD C ET AL: "PURIFICATION AND BIOLOGICAL PROPERTIES OF VASCULOTROPIN A NEW ANGIOGENIC CYTOKINE", BIOLOGY OF THE CELL, vol. 73, no. 1, 1991, pages 1 - 6, XP001070843, ISSN: 0248-4900 *
HULL M A ET AL: "ISOLATION AND CULTURE OF HUMAN GASTRIC ENDOTHELIAL CELLS", GASTROENTEROLOGY, SAUNDERS, PHILADELPHIA, PA,, US, vol. 5, no. 111, November 1996 (1996-11-01), pages 1230 - 1240, XP001068448, ISSN: 0016-5085 *
See also references of WO9846249A1 *
SZABO S ET AL: "Modulation of vascular factors by VEGF/VPF (vascular endothelial cell growth factor/vascular permeability factor) is sufficient for chronic ulcer healing and acute gastroprotection.", GASTROENTEROLOGY, vol. 112, no. 4 SUPPL., 1997, Digestive Disease Week and the 97th Annual Meeting of the American Gastroenterological Association;Washington, D.C., USA; May 11-14, 1997, pages A303, XP001068612, ISSN: 0016-5085 *

Also Published As

Publication number Publication date
EP1005355A1 (fr) 2000-06-07
WO1998046249A1 (fr) 1998-10-22

Similar Documents

Publication Publication Date Title
PL333364A1 (en) Novel compounds and method of using them
GB9617780D0 (en) Method of treatment
AU8452698A (en) Industrial fabrics and method of treatment
PL338082A1 (en) Methods of treating obesity
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
GB9715295D0 (en) Novel method of treatment
AU9016898A (en) Methods and compositions for treatment of restenosis
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
GB9715306D0 (en) Novel method of treatment
ZA983524B (en) Method of treating sepsis
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
EP1005355A4 (fr) Procede et compositions de traitement des ulceres gastro-intestinaux
EP1009433A4 (fr) Composition therapeutique et procede de traitement
GB2310318B (en) Ferroelectric component and method of manufacture
ZA98726B (en) Method of treating pulp
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
EP0929540A4 (fr) Compositions antitumorales et methodes therapeutiques
EP0912178A4 (fr) Methodes de traitement de l'hypertension
EG24199A (en) Novel method of treatment
EG24157A (en) Novel method of treatment
AUPO697197A0 (en) Composition and method of treatment
AUPO616097A0 (en) Composition and method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991112

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/00 A, 7A 61K 38/19 B, 7A 61P 1/04 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030314

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030925